AAAAAA
Results:
1-14
|
Results: 14
Authors:
Yamamoto, T
Hayashi, K
Tomura, Y
Tanaka, H
Kajiya, F
Citation: T. Yamamoto et al., Direct in vivo visualization of renal microcirculation by intravital CCD videomicroscopy, EXP NEPHROL, 9(2), 2001, pp. 150-155
In vivo visualization of characteristics of renal microcirculation in hypertensive and diabetic rats
Authors:
Yamamoto, T
Tomura, Y
Tanaka, H
Kajiya, F
Citation: T. Yamamoto et al., In vivo visualization of characteristics of renal microcirculation in hypertensive and diabetic rats, AM J P-REN, 281(3), 2001, pp. F571-F577
Authors:
Kumano, Y
Tomura, Y
Itagaki, M
Bessho, Y
Citation: Y. Kumano et al., Development of chip-on-flex using SBB flip-chip technology, MICROEL REL, 41(4), 2001, pp. 525-530
Authors:
Tsukada, J
Tahara, A
Tomura, Y
Wada, K
Kusayama, T
Ishii, N
Yatsu, T
Uchida, W
Taniguchi, N
Tanaka, A
Citation: J. Tsukada et al., Effects of YM471, a nonpeptide AVP V-1A and V-2 receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells, BR J PHARM, 133(5), 2001, pp. 746-754
Authors:
Yamamoto, T
Hayashi, K
Matsuda, H
Tomura, Y
Ogasawara, Y
Hashimoto, R
Tada, T
Tanaka, H
Kajiya, F
Citation: T. Yamamoto et al., Direct in vivo visualization of glomerular microcirculation by intravital pencil lens-probe CCD videomicroscopy, CL HEMORH M, 23(2-4), 2000, pp. 103-108
Authors:
Tahara, A
Tsukada, J
Tomura, Y
Wada, K
Kusayama, T
Ishii, N
Yatsu, T
Uchida, W
Tanaka, A
Citation: A. Tahara et al., Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells, BR J PHARM, 129(1), 2000, pp. 131-139
Authors:
Itagaki, M
Amami, K
Tomura, Y
Yuhaku, S
Ishimaru, Y
Bessho, Y
Eda, K
Ishida, T
Citation: M. Itagaki et al., Packaging properties of ALIVH-CSP using SBB flip-chip bonding technology, IEEE T AD P, 22(3), 1999, pp. 366-371
Authors:
Tomura, Y
Tahara, A
Tsukada, J
Yatsu, T
Uchida, W
Iizumi, Y
Honda, K
Citation: Y. Tomura et al., Pharmacological profile of orally administered YM087, a vasopressin antagonist, in conscious rats, CLIN EXP PH, 26(5-6), 1999, pp. 399-403
Authors:
Tahara, A
Tsukada, J
Ishii, N
Tomura, Y
Wada, K
Kusayama, T
Yatsu, T
Uchida, W
Tanaka, A
Citation: A. Tahara et al., Characterization of rodent liver and kidney AVP receptors: pharmacologic evidence for species differences, REGUL PEPT, 84(1-3), 1999, pp. 13-19
Authors:
Tahara, A
Saito, M
Sugimoto, T
Tomura, Y
Wada, K
Kusayama, T
Tsukada, J
Ishii, N
Yatsu, T
Uchida, W
Tanaka, A
Citation: A. Tahara et al., AVP-induced mitogenic responses of Chinese hamster ovary cells expressing human V-1A or V-1B receptors, PFLUG ARCH, 437(2), 1999, pp. 219-226
Authors:
Tahara, A
Tsukada, J
Ishii, N
Tomura, Y
Wada, K
Kusayama, T
Yatsu, T
Uchida, W
Tanaka, A
Citation: A. Tahara et al., Comparison of vasopressin binding sites in human uterine and vascular smooth muscle cells, EUR J PHARM, 378(1), 1999, pp. 137-142
Authors:
Yatsu, T
Tomura, Y
Tahara, A
Wada, K
Kusayama, T
Tsukada, J
Tokioka, T
Uchida, W
Inagaki, O
Iizumi, Y
Tanaka, A
Honda, K
Citation: T. Yatsu et al., Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V-1A and V-2 receptor antagonist, in dogs with pacing-induced congestive heart failure, EUR J PHARM, 376(3), 1999, pp. 239-246
Authors:
Tahara, A
Saito, M
Tsukada, J
Ishii, N
Tomura, Y
Wada, K
Kusayama, T
Yatsu, T
Uchida, W
Tanaka, A
Citation: A. Tahara et al., Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells, EUR J PHARM, 368(1), 1999, pp. 89-94
Authors:
Tahara, A
Saito, M
Sugimoto, T
Tomura, Y
Wada, K
Kusayama, T
Tsukada, J
Ishii, N
Yatsu, T
Uchida, W
Tanaka, A
Citation: A. Tahara et al., Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells, BR J PHARM, 125(7), 1998, pp. 1463-1470
Risultati:
1-14
|